Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
24
NVOS Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
28.71%
Day range:
$0.0025 - $0.0025
52-week range:
$0.0001 - $0.0990
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.00x
Volume:
3.5K
Avg. volume:
6.7K
1-year change:
-93.75%
Market cap:
$49.3K
Revenue:
$13.3M
EPS (TTM):
-$0.67
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NVOS
Novo Integrated Sciences, Inc.
|
-- | -- | -- | -- | -- |
|
AMS
American Shared Hospital Services
|
$7.5M | -- | -3.19% | -100% | $4.50 |
|
ASTH
Astrana Health, Inc.
|
$952.8M | $0.61 | 39.88% | 82.8% | $37.6667 |
|
CCEL
Cryo-Cell International, Inc.
|
$7.7M | -$0.09 | -4.04% | -60.92% | $8.50 |
|
HSMD
Healthcare Solutions Management Group, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NVOS
Novo Integrated Sciences, Inc.
|
$0.0025 | -- | $49.3K | -- | $0.00 | 0% | 0.00x |
|
AMS
American Shared Hospital Services
|
$2.12 | $4.50 | $13.9M | 11.73x | $0.00 | 0% | 0.47x |
|
ASTH
Astrana Health, Inc.
|
$24.0100 | $37.6667 | $1.2B | 126.37x | $0.00 | 0% | 0.41x |
|
CCEL
Cryo-Cell International, Inc.
|
$3.68 | $8.50 | $29.7M | 498.00x | $0.15 | 17.66% | 0.94x |
|
HSMD
Healthcare Solutions Management Group, Inc.
|
$0.0002 | -- | $18.4K | -- | $0.00 | 0% | 0.00x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NVOS
Novo Integrated Sciences, Inc.
|
12.88% | 29.963 | 31.81% | 0.28x |
|
AMS
American Shared Hospital Services
|
50.05% | 0.126 | 110.57% | 1.02x |
|
ASTH
Astrana Health, Inc.
|
58.37% | -0.163 | 92.2% | 1.34x |
|
CCEL
Cryo-Cell International, Inc.
|
-564.01% | 1.723 | 33.28% | 0.78x |
|
HSMD
Healthcare Solutions Management Group, Inc.
|
-- | -2.853 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NVOS
Novo Integrated Sciences, Inc.
|
$1.3M | -$1.5M | -44.59% | -49.15% | -47.07% | -$1.7M |
|
AMS
American Shared Hospital Services
|
$1.6M | $48K | -6.67% | -12.09% | 0.67% | -$2M |
|
ASTH
Astrana Health, Inc.
|
$81.6M | $19.2M | 0.88% | 1.85% | 2.01% | $7.4M |
|
CCEL
Cryo-Cell International, Inc.
|
$5.8M | $1.9M | -20.01% | -- | 24.29% | $2.5M |
|
HSMD
Healthcare Solutions Management Group, Inc.
|
-- | -- | -- | -- | -- | -- |
Novo Integrated Sciences, Inc. vs. Competitors
-
Which has Higher Returns NVOS or AMS?
American Shared Hospital Services has a net margin of -86.61% compared to Novo Integrated Sciences, Inc.'s net margin of -4.59%. Novo Integrated Sciences, Inc.'s return on equity of -49.15% beat American Shared Hospital Services's return on equity of -12.09%.
Company Gross Margin Earnings Per Share Invested Capital NVOSNovo Integrated Sciences, Inc.41.76% -$0.16 $25.2M AMSAmerican Shared Hospital Services21.94% -$0.00 $53.2M -
What do Analysts Say About NVOS or AMS?
Novo Integrated Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand American Shared Hospital Services has an analysts' consensus of $4.50 which suggests that it could grow by 112.26%. Given that American Shared Hospital Services has higher upside potential than Novo Integrated Sciences, Inc., analysts believe American Shared Hospital Services is more attractive than Novo Integrated Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NVOSNovo Integrated Sciences, Inc.0 0 0 AMSAmerican Shared Hospital Services0 0 0 -
Is NVOS or AMS More Risky?
Novo Integrated Sciences, Inc. has a beta of 1.472, which suggesting that the stock is 47.224% more volatile than S&P 500. In comparison American Shared Hospital Services has a beta of 0.122, suggesting its less volatile than the S&P 500 by 87.793%.
-
Which is a Better Dividend Stock NVOS or AMS?
Novo Integrated Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. American Shared Hospital Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Novo Integrated Sciences, Inc. pays -- of its earnings as a dividend. American Shared Hospital Services pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVOS or AMS?
Novo Integrated Sciences, Inc. quarterly revenues are $3.2M, which are smaller than American Shared Hospital Services quarterly revenues of $7.2M. Novo Integrated Sciences, Inc.'s net income of -$2.7M is lower than American Shared Hospital Services's net income of -$329K. Notably, Novo Integrated Sciences, Inc.'s price-to-earnings ratio is -- while American Shared Hospital Services's PE ratio is 11.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Novo Integrated Sciences, Inc. is 0.00x versus 0.47x for American Shared Hospital Services. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVOSNovo Integrated Sciences, Inc.0.00x -- $3.2M -$2.7M AMSAmerican Shared Hospital Services0.47x 11.73x $7.2M -$329K
-
Which has Higher Returns NVOS or ASTH?
Astrana Health, Inc. has a net margin of -86.61% compared to Novo Integrated Sciences, Inc.'s net margin of 0.11%. Novo Integrated Sciences, Inc.'s return on equity of -49.15% beat Astrana Health, Inc.'s return on equity of 1.85%.
Company Gross Margin Earnings Per Share Invested Capital NVOSNovo Integrated Sciences, Inc.41.76% -$0.16 $25.2M ASTHAstrana Health, Inc.8.54% $0.01 $1.6B -
What do Analysts Say About NVOS or ASTH?
Novo Integrated Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Astrana Health, Inc. has an analysts' consensus of $37.6667 which suggests that it could grow by 56.88%. Given that Astrana Health, Inc. has higher upside potential than Novo Integrated Sciences, Inc., analysts believe Astrana Health, Inc. is more attractive than Novo Integrated Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NVOSNovo Integrated Sciences, Inc.0 0 0 ASTHAstrana Health, Inc.8 2 0 -
Is NVOS or ASTH More Risky?
Novo Integrated Sciences, Inc. has a beta of 1.472, which suggesting that the stock is 47.224% more volatile than S&P 500. In comparison Astrana Health, Inc. has a beta of 0.862, suggesting its less volatile than the S&P 500 by 13.753%.
-
Which is a Better Dividend Stock NVOS or ASTH?
Novo Integrated Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Astrana Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Novo Integrated Sciences, Inc. pays -- of its earnings as a dividend. Astrana Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVOS or ASTH?
Novo Integrated Sciences, Inc. quarterly revenues are $3.2M, which are smaller than Astrana Health, Inc. quarterly revenues of $956M. Novo Integrated Sciences, Inc.'s net income of -$2.7M is lower than Astrana Health, Inc.'s net income of $1.1M. Notably, Novo Integrated Sciences, Inc.'s price-to-earnings ratio is -- while Astrana Health, Inc.'s PE ratio is 126.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Novo Integrated Sciences, Inc. is 0.00x versus 0.41x for Astrana Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVOSNovo Integrated Sciences, Inc.0.00x -- $3.2M -$2.7M ASTHAstrana Health, Inc.0.41x 126.37x $956M $1.1M
-
Which has Higher Returns NVOS or CCEL?
Cryo-Cell International, Inc. has a net margin of -86.61% compared to Novo Integrated Sciences, Inc.'s net margin of 9.58%. Novo Integrated Sciences, Inc.'s return on equity of -49.15% beat Cryo-Cell International, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital NVOSNovo Integrated Sciences, Inc.41.76% -$0.16 $25.2M CCELCryo-Cell International, Inc.74.61% $0.09 -$2.2M -
What do Analysts Say About NVOS or CCEL?
Novo Integrated Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Cryo-Cell International, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 130.9%. Given that Cryo-Cell International, Inc. has higher upside potential than Novo Integrated Sciences, Inc., analysts believe Cryo-Cell International, Inc. is more attractive than Novo Integrated Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NVOSNovo Integrated Sciences, Inc.0 0 0 CCELCryo-Cell International, Inc.0 1 0 -
Is NVOS or CCEL More Risky?
Novo Integrated Sciences, Inc. has a beta of 1.472, which suggesting that the stock is 47.224% more volatile than S&P 500. In comparison Cryo-Cell International, Inc. has a beta of 0.669, suggesting its less volatile than the S&P 500 by 33.089%.
-
Which is a Better Dividend Stock NVOS or CCEL?
Novo Integrated Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cryo-Cell International, Inc. offers a yield of 17.66% to investors and pays a quarterly dividend of $0.15 per share. Novo Integrated Sciences, Inc. pays -- of its earnings as a dividend. Cryo-Cell International, Inc. pays out 510.2% of its earnings as a dividend.
-
Which has Better Financial Ratios NVOS or CCEL?
Novo Integrated Sciences, Inc. quarterly revenues are $3.2M, which are smaller than Cryo-Cell International, Inc. quarterly revenues of $7.8M. Novo Integrated Sciences, Inc.'s net income of -$2.7M is lower than Cryo-Cell International, Inc.'s net income of $749.4K. Notably, Novo Integrated Sciences, Inc.'s price-to-earnings ratio is -- while Cryo-Cell International, Inc.'s PE ratio is 498.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Novo Integrated Sciences, Inc. is 0.00x versus 0.94x for Cryo-Cell International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVOSNovo Integrated Sciences, Inc.0.00x -- $3.2M -$2.7M CCELCryo-Cell International, Inc.0.94x 498.00x $7.8M $749.4K
-
Which has Higher Returns NVOS or HSMD?
Healthcare Solutions Management Group, Inc. has a net margin of -86.61% compared to Novo Integrated Sciences, Inc.'s net margin of --. Novo Integrated Sciences, Inc.'s return on equity of -49.15% beat Healthcare Solutions Management Group, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital NVOSNovo Integrated Sciences, Inc.41.76% -$0.16 $25.2M HSMDHealthcare Solutions Management Group, Inc.-- -- -- -
What do Analysts Say About NVOS or HSMD?
Novo Integrated Sciences, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Healthcare Solutions Management Group, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Novo Integrated Sciences, Inc. has higher upside potential than Healthcare Solutions Management Group, Inc., analysts believe Novo Integrated Sciences, Inc. is more attractive than Healthcare Solutions Management Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NVOSNovo Integrated Sciences, Inc.0 0 0 HSMDHealthcare Solutions Management Group, Inc.0 0 0 -
Is NVOS or HSMD More Risky?
Novo Integrated Sciences, Inc. has a beta of 1.472, which suggesting that the stock is 47.224% more volatile than S&P 500. In comparison Healthcare Solutions Management Group, Inc. has a beta of 2,230.863, suggesting its more volatile than the S&P 500 by 222986.26%.
-
Which is a Better Dividend Stock NVOS or HSMD?
Novo Integrated Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthcare Solutions Management Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Novo Integrated Sciences, Inc. pays -- of its earnings as a dividend. Healthcare Solutions Management Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVOS or HSMD?
Novo Integrated Sciences, Inc. quarterly revenues are $3.2M, which are larger than Healthcare Solutions Management Group, Inc. quarterly revenues of --. Novo Integrated Sciences, Inc.'s net income of -$2.7M is higher than Healthcare Solutions Management Group, Inc.'s net income of --. Notably, Novo Integrated Sciences, Inc.'s price-to-earnings ratio is -- while Healthcare Solutions Management Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Novo Integrated Sciences, Inc. is 0.00x versus 0.00x for Healthcare Solutions Management Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVOSNovo Integrated Sciences, Inc.0.00x -- $3.2M -$2.7M HSMDHealthcare Solutions Management Group, Inc.0.00x -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is down 0.27% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
